Today: 7 June 2026
Nuclear decision gives Constellation boost, but CEG stock slides
7 June 2026
2 mins read

Nuclear decision gives Constellation boost, but CEG stock slides

NEW YORK, June 6, 2026, 18:04 EDT

Constellation Energy Corp. (CEG.O) slipped 3.7% to finish at $254.83 on Friday, trading well below the $287.75 Nasdaq last sale price listed in its May 29 prospectus supplement for this week’s shareholder offering. Shares stayed weak going into the weekend, even after a regulatory decision favored the company’s Three Mile Island restart plan.

Timing is an issue. U.S. stocks are closed for the weekend, as Nasdaq trades only Monday to Friday, 9:30 a.m. to 4 p.m. ET. Investors get a pause to weigh a week packed with new stock supply, rate concerns and nuclear-power headlines before trading starts again Monday.

Constellation is now a big example for traders looking at how AI data centers could drive 24/7 power demand. The Baltimore company, with around 55 GW of generating capacity, is the top U.S. nuclear operator and serves about 2.5 million customer accounts.

Constellation’s stock came under pressure after a secondary offering announced June 1. Shareholders planned to sell 11 million shares at $281 each, with no new shares issued and the company getting none of the cash. Constellation also said it would buy back 2 million shares from the underwriters.

The offering and buyback finished up on June 2, according to a later filing. Constellation spent around $558 million to buy back shares. About $3.5 billion is still available on its buyback plan. Underwriters have a 30-day option to buy as many as 1.35 million more shares from the sellers.

Stocks took a hit Friday. A hot U.S. jobs report rattled markets and fueled bets the Fed will keep rates higher. The Dow shed 1.35%, the S&P 500 slid 2.64%, and the Nasdaq was off 4.18%. “The dam just broke,” said Ryan Detrick, chief market strategist at Carson Group, after stocks had held up for weeks. Wells Fargo’s Ohsung Kwon said the drop was “more driven by positioning than fundamentals.” Reuters

U.S. regulators gave Constellation a boost. The Federal Energy Regulatory Commission granted a waiver that should let the company move grid rights from its Eddystone gas plant to the former Three Mile Island nuclear site in Pennsylvania. Constellation wants to restart the plant as the Crane Clean Energy Center to power Microsoft data centers. The waiver covers the rights needed to deliver electricity onto the grid.

The move kept a main part of the bull case in play. In May, Chief Executive Joe Dominguez dismissed talk that the plant might be delayed to 2031, saying, “I don’t want anybody” thinking the plant won’t restart earlier. Reuters noted no fully closed U.S. nuclear plant has ever restarted, making the outcome a big deal for investors. Reuters

Constellation wasn’t the only one hit. Vistra dropped 3.2% on Friday while NRG Energy slipped 3.1%, adding pressure across independent power stocks that have seen investors pile in on bets tied to growing electricity demand.

But the risks are real. A lock-up on shares issued during Constellation’s Calpine deal is set to expire in two stages, with half coming off June 30, 2026 and the rest on June 30, 2027. There are also execution and grid risks for the Crane project. Utility Dive said PJM feedback flagged required transmission upgrades and said the project might be delayed past the company’s target.

CEG faces a key week as traders decide if the recent dip is chance or a red flag. Focus is on the $281 offering price, plus whether underwriters take up more shares, and what comes next from PJM or Constellation about the Crane schedule. Macro headwinds are clear: if rate worries keep hitting growth and demand bets, CEG could struggle to bounce back on nuclear headlines alone.

Stock Market Today

  • Why Americas Gold and Silver Shares Drop 19.7% Despite High-Grade Cosalá Drill Results
    June 6, 2026, 6:16 PM EDT. Americas Gold and Silver (TSX:USA) shares fell 19.7% following the announcement of infill drill results at its Cosalá Complex, which revealed silver grades up to five times higher than the current resource model. The company is conducting its largest drilling program through 2026, aiming to revise its mine plan and reserves to reflect these findings. Despite the promising grades, the stock decline reflects investor concerns over recent dilution, insider selling, a new management team, and execution risks across its Cosalá, Galena, and Crescent projects. The shares currently trade below some fair value estimates ranging from US$12.29 to US$33.60, highlighting divergent views on the company's prospects. Key near-term catalysts include reserve updates, 2026 production guidance, and Crescent's timely restart without additional financial strain.

Latest articles

Nuclear decision gives Constellation boost, but CEG stock slides

Nuclear decision gives Constellation boost, but CEG stock slides

7 June 2026
Constellation Energy shares closed at $254.83, down 3.7% and 11% below the $287.75 price in last week’s prospectus, after a shareholder offering and despite a regulatory win for its Three Mile Island restart plan; investors now face a weekend to digest new stock supply, rate worries, and nuclear project risks before Monday’s open.
Portnoy’s Bitcoin, XRP Losses Mount In $390B Crypto Drop

Portnoy’s Bitcoin, XRP Losses Mount In $390B Crypto Drop

7 June 2026
Strategy’s surprise sale of 32 Bitcoin for $2.5 million to fund preferred stock distributions rattled investors, raising fears it may sell more to meet obligations, as Bitcoin and Ether posted their worst weekly losses since 2022 and crypto-linked stocks like Coinbase and Robinhood plunged up to 11% amid a $390 billion market wipeout.
Bitcoin Hits $60,000 As Crypto Selloff Deepens

Bitcoin Drops as ETF Outflows Mount, $60,000 Support Weakens

7 June 2026
Bitcoin plunged below $60,000 for the first time since October 2024, triggering $4.4 billion in spot ETF outflows and a rare bitcoin sale by Strategy, while crypto-linked stocks tumbled and analysts warned that further drops below $59,750 could spark more selling pressure or a deeper slide.
Johnson & Johnson Shares Hold Up in Market Selloff — Looking at What May Shift JNJ Next Week

Johnson & Johnson Shares Hold Up in Market Selloff — Looking at What May Shift JNJ Next Week

6 June 2026
Johnson & Johnson jumped 2.02% to $232.77 Friday—outperforming a plunging S&P 500—after a Los Angeles jury found the company not negligent in a talc cancer lawsuit; investors now eye next week’s Goldman Sachs healthcare conference and a fresh $1.34 dividend, as J&J touts new drug launches and raised its 2026 outlook despite ongoing litigation and Stelara sales declines.
Eli Lilly Stock Sets High Ahead of Monday Data

Eli Lilly Stock Sets High Ahead of Monday Data

6 June 2026
Eli Lilly shares hit a record $1,131.42 close Friday, up 0.6%, after late-stage data showed its experimental retatrutide cut sleep apnea severity by 60.6% and knee osteoarthritis pain by up to 73.1% in obese adults; investors will watch Monday’s trade to see if the new results justify Lilly’s premium as the S&P 500 tumbled 2.64% Friday and rivals like Roche posted strong obesity-drug data.
Portnoy’s Bitcoin, XRP Losses Mount In $390B Crypto Drop
Previous Story

Portnoy’s Bitcoin, XRP Losses Mount In $390B Crypto Drop

Go toTop